//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
ET Markets
12,132.6076.8
Stock Analysis, IPO, Mutual Funds, Bonds & More

AstraZeneca Pharma India Ltd.

ET 500

Rank 2019
0
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    14:29 | 29-01-2020
  • BSE
    14:34 | 29-01-2020
2675.00

Today's Change

40.70 (1.55%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

12,908

Open

2654.00

Prev. Close

2634.30

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)29.94
  • BV/share (₹)120.32
  • 52Wk L/H1570.00/ 2931.85
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed
AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
AstraZeneca Pharma India Ltd.Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, February 3, 2020| Announcement
AstraZeneca Pharma India Ltd.Shareholding for the Period Ended December 31, 2019| Announcement
AstraZeneca Pharma India Ltd.Statement Of Investor Complaints For The Quarter Ended December 2019| Announcement
AstraZeneca Pharma India Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
AstraZeneca Pharma India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
AstraZeneca Pharma India Ltd.Disclosure Of Related Party Transactions| Announcement
AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
AstraZeneca Pharma India Ltd.Outcome of Board Meeting| Announcement
AstraZeneca Pharma India Ltd.Outcome Of The Board Meeting Held On Monday, November 11, 2019| Announcement
AstraZeneca Pharma India Ltd.Intimation Regarding Chairmanship Of Stakeholders Relationship Committee| Announcement
AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
AstraZeneca Pharma India Ltd.Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, November 11, 2019| Announcement
AstraZeneca Pharma India Ltd.Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015| Announcement
AstraZeneca Pharma India Ltd.Shareholding for the Period Ended September 30, 2019| Announcement
AstraZeneca Pharma India Ltd.Launch Of Durvalumab (Imfinzi) In India| Announcement
AstraZeneca Pharma India Ltd.Statement Of Investor Complaints For The Quarter Ended September 2019| Announcement
AstraZeneca Pharma India Ltd.Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015| Announcement
AstraZeneca, STEMI India collaborate| News
AstraZeneca Q3 net profit at Rs 8.67 crore| News
AstraZeneca Pharma India Ltd. share price up by 1.55% from its previous close of Rs 2634.30. AstraZeneca Pharma India Ltd. stock last traded price is 2675.00
AstraZeneca Pharma India Ltd. Share Price
Value
Today/Current/Last
2675.00
Previous Day
2634.30
What's your view on AstraZeneca Pharma India for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on AstraZeneca Pharma India Ltd.

AstraZeneca Pharma India Ltd.
Quarterly Results

Figures in Rs. Cr
Sep 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
208.48
1.92
29.20
0.39
1054.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Operating Profit
33.56
-5.63
127.32
-1.94
696.44
Other Income
3.16
5.74
-5.77
0.00
44.75
EBITDA
36.72
-4.75
102.68
-1.91
233.03
Interest
0.28
-3.99
0.00
0.00
2.62
Depreciation
4.64
0.29
26.32
0.00
26.00
Tax
17.38
43.48
227.19
-0.55
84.58
Net Profit
14.42
-33.00
57.86
-3.34
502.79
EPS (₹)
5.77
-32.98
58.08
-3.33
83.93

AstraZeneca Pharma India Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
2674.50
1.53
5.74
-0.50
3.30
67.08
178.01
207.20
1699.00
0.74
4.78
5.01
6.57
20.63
23.84
-1.35
6725.20
0.00
1.00
-3.70
1.30
5.90
60.67
100.52
4290.00
-0.87
7.49
3.00
9.22
47.26
138.43
104.31
12659.75
0.05
-0.33
-4.05
6.59
57.30
185.71
217.21
4411.75
-0.55
1.81
3.48
-10.36
41.78
371.37
366.85
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

AstraZeneca Pharma India Ltd Risk Return Comparison

with peersNew

AstraZeneca Pharma India Ltd
Financial Comparison

with peers
Management Efficiency
AstraZeneca Pharma India Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
18.10
-4.97
-89.75
29.69
Return on Assets (%)
9.69
0.85
-29.24
24.99
Return on capital Employed (%)
15.49
-1.61
-49.70
19.18
Fixed Assets Turnover (x)
2.66
1.07
0.06
2.70
Profitability and Growth
Gross Profit Margin (%)
7.74
-1.61
-38.91
19.72
Operating Profit Margin(%)
9.79
6.50
-17.53
21.99
Net Profit margin (%)
7.47
-4.59
-82.36
47.92
Financial Strength
Liquidity
Quick Ratio (x)
1.30
3.25
0.59
7.69
Current Ratio (x)
1.84
4.07
1.01
8.89
Cash ratio (x)
0.66
1.16
0.00
3.92
Solvency
Debt Equity Ratio (x)
0.00
0.55
0.00
4.31
Coverage Ratios
Cash flows to long term debt (x)
0.00
6.09
0.00
41.88
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

AstraZeneca Pharma India Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
ForeignInstitutions512,0292.05
ForeignPromoter18,750,00075.00
GeneralPublic3,978,16915.91
NBanksMutualFunds838,4013.35
Others832,3993.33
FinancialInstitutions89,0020.36

MF Ownership Of AstraZeneca Pharma India Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Equity: ELSS
395559
0.00%
1.54%
103.50
Nippon India Small Cap Direct-G
Portfolio as on 31-12-2019
Equity: Small Cap
377684
0.00%
1.16%
98.82
Equity: Sectoral-Pharma
57467
-11.42%
1.17%
15.04
Tata India Pharma & HealthCare Direct-G
Portfolio as on 31-12-2019
Equity: Sectoral-Pharma
5000
100.00%
0.79%
1.31
IDBI Healthcare Fund Direct-G
Portfolio as on 31-12-2019
Equity: Sectoral-Pharma
2325
0.00%
1.94%
0.61

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About AstraZeneca Pharma India Ltd.

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 6558.25 Crore) operating in Pharmaceuticals sector.

AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 683.31 Crore to Sales Value (93.82 % of Total Sales), Sale of services which contributed Rs 23.62 Crore to Sales Value (3.24 % of Total Sales), Other Operating Revenue which contributed Rs 21.31 Crore to Sales Value (2.92 % of Total Sales) and Scrap which contributed Rs .05 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Standalone sales of Rs 208.48 Crore, up 1.92 % from last quarter Sales of Rs 204.56 Crore and up 29.20 % from last year same quarter Sales of Rs 161.36 Crore Company has reported net profit after tax of Rs 14.42 Crore in latest quarter.

The company’s top management includes Mr.Gagandeep Singh Bedi, Mr.Ian John Parish, Mr.Narayan K Seshadri, Mr.Rajesh Marwaha, Ms.Kimsuka Narsimhan, Ms.Revathy Ashok, Ms.Weiying Sarah Wang. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditoRs As on 31-12-2019, the company has a total of 25,000,000 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors